Tumor ablation is referred to as a minimally invasive technique that is commonly used in the treatment of tumors of the liver, kidney, bone, and lung among others. It can be used as a first-line treatment or in cases of failed chemotherapy or radiotherapy or for any non-surgical candidates. Tumor Ablation systems in general comprise a generator and a needlelike device that delivers the energy directly to the targeted tissue to cause acute cellular necrosis.
Major Key Players of the Tumor Ablation Market are:Medtronic, Integra LifeSciences Corporation, AngioDynamics, Boston Scientific Corporation, NeuWave Medical, (Johnson & Johnson Services), Galil Medical Inc. (BTG International Ltd), Misonix, HealthTronics, Inc., Sonacare Medical, MERMAID MEDICAL A/S among others.
No comments:
Post a Comment